Industry reports
Editor highlights

Search inside this page

Publishers

All regions

Free Market Research Guides to Download

Pathology Analysis & Statistics, May 2013 (p30)

You might be interested in: cancer, breast cancer, prostate cancer, more »

» Purchase Premium Reports

871-920 of about 5 600 reports
Evotec AG - Product Pipeline Review - 2013

Evotec AG - Product Pipeline Review - 2013

  • $ 1 500
  • Company report
  • December 2013
  • by Global Markets Direct

Evotec AG - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, “Evotec AG - Product Pipeline Review - 2013” provides data on the Evotec AG's research and development ...

  • Industries : Pathology
  • Countries : World
Hypoglycemia - Pipeline Review, H2 2013

Hypoglycemia - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Hypoglycemia - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Hypoglycemia - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...

  • Industries : Pathology
  • Countries : World
ReGenX Biosciences, LLC - Product Pipeline Review - 2013

ReGenX Biosciences, LLC - Product Pipeline Review - 2013

  • $ 1 500
  • Company report
  • December 2013
  • by Global Markets Direct

ReGenX Biosciences, LLC - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, “ReGenX Biosciences, LLC - Product Pipeline Review - 2013” provides data on the ReGenX ...

  • Industries : Pathology
  • Countries : World
Shigella Infections (Shigellosis) - Pipeline Review, H2 2013

Shigella Infections (Shigellosis) - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Shigella Infections (Shigellosis) - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Shigella Infections (Shigellosis) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic ...

  • Industries : Pathology
  • Countries : World
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2013

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic ...

  • Industries : Pathology
  • Countries : World
Arteriosclerosis - Pipeline Review, H2 2013

Arteriosclerosis - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Arteriosclerosis - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Arteriosclerosis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Pathology
  • Countries : World, United States
Bullous Pemphigoid - Pipeline Review, H2 2013

Bullous Pemphigoid - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Bullous Pemphigoid - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Bullous Pemphigoid - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report ...

  • Industries : Pathology
  • Countries : World
Acute Promyelocytic Leukemia - Pipeline Review, H2 2013

Acute Promyelocytic Leukemia - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Acute Promyelocytic Leukemia - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Acute Promyelocytic Leukemia - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic ...

  • Industries : Pathology
  • Countries : World
Hepatic (Liver) Metastasis - Pipeline Review, H2 2013

Hepatic (Liver) Metastasis - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Hepatic (Liver) Metastasis - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Hepatic (Liver) Metastasis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. ...

  • Industries : Pathology
  • Countries : United States
Aplastic Anemia - Pipeline Review, H2 2013

Aplastic Anemia - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Aplastic Anemia - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Aplastic Anemia - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Pathology
  • Countries : World
World Pathology: Bacterial Conjunctivitis – Pipeline Review, H2 2011

World Pathology: Bacterial Conjunctivitis – Pipeline Review, H2 2011

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Islet Cell Carcinoma (Insulinoma) – Pipeline Review, H2 2011 Global Industries Direct’s, 'Islet Cell Carcinoma (Insulinoma) - Pipeline Review, H2 2011', provides an overview of the Islet Cell Carcinoma ...

  • Industries : Pathology
  • Countries : United States
Corneal Neovascularization - Pipeline Review, H2 2013

Corneal Neovascularization - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Corneal Neovascularization - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Corneal Neovascularization - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. ...

  • Industries : Pathology
  • Countries : World
Rhabdomyosarcoma - Pipeline Review, H2 2013

Rhabdomyosarcoma - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Rhabdomyosarcoma - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Rhabdomyosarcoma - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Pathology
  • Countries : World
Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2013

Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2013', provides an overview of the indication's ...

  • Industries : Pathology
  • Countries : World
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H2 2013

Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Clostridium Difficile Infections (Clostridium Difficile Associated ...

  • Industries : Pathology
Swine Influenza - Pipeline Review, H2 2013

Swine Influenza - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Swine Influenza - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Swine Influenza - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Pathology
  • Countries : World
Retinopathy - Pipeline Review, H2 2013

Retinopathy - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Retinopathy - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Retinopathy - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...

  • Industries : Pathology
  • Countries : World
Skin Infections - Pipeline Review, H2 2013

Skin Infections - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Skin Infections - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Skin Infections - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Pathology
  • Countries : World
Cancer Cachexia - Pipeline Review, H2 2013

Cancer Cachexia - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Cancer Cachexia - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Cancer Cachexia - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Pathology
  • Countries : United States, World
Androgenic Alopecia - Pipeline Review, H2 2013

Androgenic Alopecia - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Androgenic Alopecia - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Androgenic Alopecia - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report ...

  • Industries : Pathology
  • Countries : World
Haemophilus Influenzae Infections - Pipeline Review, H2 2013

Haemophilus Influenzae Infections - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Haemophilus Influenzae Infections - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Haemophilus Influenzae Infections - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic ...

  • Industries : Pathology
  • Countries : Japan, World
Primary Biliary Cirrhosis - Pipeline Review, H2 2013

Primary Biliary Cirrhosis - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Primary Biliary Cirrhosis - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Primary Biliary Cirrhosis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. ...

  • Industries : Pathology
  • Countries : World
Warts - Pipeline Review, H2 2013

Warts - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Warts - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Warts - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on ...

  • Industries : Pathology
  • Countries : World
Nasopharyngitis (Common Cold) - Pipeline Review, H2 2013

Nasopharyngitis (Common Cold) - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Nasopharyngitis (Common Cold) - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Nasopharyngitis (Common Cold) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic ...

  • Industries : Pathology
  • Countries : World
Burkholderia Infections - Pipeline Review, H2 2013

Burkholderia Infections - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Burkholderia Infections - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Burkholderia Infections - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. ...

  • Industries : Pathology
  • Countries : World
Gaucher's Disease - Pipeline Review, H2 2013

Gaucher's Disease - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Gaucher's Disease - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Gaucher's Disease - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report ...

  • Industries : Pathology
  • Countries : World
Hypoxic-Ischemic Encephalopathy - Pipeline Review, H2 2013

Hypoxic-Ischemic Encephalopathy - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Hypoxic-Ischemic Encephalopathy - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Hypoxic-Ischemic Encephalopathy - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic ...

  • Industries : Pathology
  • Countries : World
Frontier Pharma: Systemic Lupus Erythematosus - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Systemic Lupus Erythematosus - Identifying and Commercializing First-in-Class Innovation

  • $ 3 500
  • Industry report
  • December 2013
  • by GBI Research

Frontier Pharma: Systemic Lupus Erythematosus - Identifying and Commercializing First-in-Class Innovation Summary The Systemic Lupus Erythematosus (SLE) drug market is currently under-served by non-generic, ...

  • Industries : Pathology
  • Countries : World
Lucentis (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022

Lucentis (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2013
  • by Global Data

Lucentis (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022 Summary The entire market for microvascular complications of diabetes (MCD) - diabetic nephropathy, retinopathy, ...

  • Industries : Pathology
  • Countries : Japan, Spain, Italy, France, Germany, World, United States, United Kingdom, Europe
Avastin (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022

Avastin (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2013
  • by Global Data

Avastin (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022 Summary The entire market for microvascular complications of diabetes (MCD) - diabetic nephropathy, retinopathy, ...

  • Industries : Pathology
  • Countries : Japan, Spain, Italy, France, Germany, World, United States, United Kingdom, Europe

» View Public Reports

About 12 000 reports

U.S. Pharmaceutical Industry Analysis

  • Industry report
  • April 2014
  • 129 pages

... Of work are implicated as important causes of hypertension, as well as cvd., E.G. Job strain 96 schnall pl et al. Why the workplace and cardiovascular disease. In: schnall pl, belkic kl, landsbergis pa ...


» Read our Company Profiles

About 200 Companies

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

Pfizer Inc.

United States

Johnson and Johnson

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.